Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide.
Caffo O, Basso U, Cattrini C, Ermacora P, Maruzzo M, Alberti M, Anesi C, Bimbatti D, Cani M, Crespi V, Farinea G, Kadrija D, Kinspergher S, Lai E, Lay L, Maines F, Mennitto A, Pierantoni F, Samuelly A, Urban S, Buttigliero C, Veccia A. Caffo O, et al. Among authors: maines f. Clin Genitourin Cancer. 2024 Nov 12;23(1):102265. doi: 10.1016/j.clgc.2024.102265. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39662149
Organized prostate cancer screening program: a proposal from the Italian Society of Urology (SIU).
Ficarra V, Bartoletti R, Borghesi M, Caffo O, DE Nunzio C, Falagario UG, Gandaglia G, Giannarini G, Minervini A, Mirone V, Porpiglia F, Rocco B, Salonia A, Verze P, Carrieri G; Italian Society of Urology (SIU) panel. Ficarra V, et al. Minerva Urol Nephrol. 2024 Oct;76(5):519-529. doi: 10.23736/S2724-6051.24.06117-2. Minerva Urol Nephrol. 2024. PMID: 39320244 Free article.
Italian Registry on Rare Urological Tumors (Meet-URO-23): The First Analysis on Collecting Duct Carcinoma of the Kidney.
Giudice GC, Maruzzo M, Verzoni E, Procopio G, Bimbatti D, Sepe P, Maines F, Grillone F, Cavo A, Santoni M, Cordua N, Pecoraro G, Prati V, Napoli MD, Ollari E, Caruso G, Simoni N, Campobasso D, Buti S. Giudice GC, et al. Among authors: maines f. Clin Genitourin Cancer. 2024 Oct;22(5):102186. doi: 10.1016/j.clgc.2024.102186. Epub 2024 Aug 2. Clin Genitourin Cancer. 2024. PMID: 39179427 Free article.
Complete pathological response to pembrolizumab in pretreated pancreatic acinar cell carcinoma.
Merz V, Maines F, Marcucci S, Sartori C, Frisinghelli M, Trentin C, Kadrija D, Carbone FG, Michielan A, Gabbrielli A, Melisi D, Barbareschi M, Brolese A, Caffo O. Merz V, et al. Among authors: maines f. J Cancer Res Clin Oncol. 2024 Jul 11;150(7):347. doi: 10.1007/s00432-024-05841-z. J Cancer Res Clin Oncol. 2024. PMID: 38990367 Free PMC article.
The Role of Fast and Deep PSA Response in Castration-sensitive Prostate Cancer.
Iacovelli R, Ciccarese C, Caffo O, De Giorgi U, Basso U, Tucci M, Mosillo C, Maruzzo M, Maines F, Casadei C, Milella M, Tortora G. Iacovelli R, et al. Among authors: maines f. Anticancer Res. 2022 Jan;42(1):165-172. doi: 10.21873/anticanres.15470. Anticancer Res. 2022. PMID: 34969722
Docetaxel and prednisone with or without enzalutamide as first-line treatment in patients with metastatic castration-resistant prostate cancer: CHEIRON, a randomised phase II trial.
Caffo O, Ortega C, Nolè F, Gasparro D, Mucciarini C, Aieta M, Zagonel V, Iacovelli R, De Giorgi U, Facchini G, Veccia A, Palesandro E, Verri E, Buti S, Razzini G, Bozza G, Maruzzo M, Ciccarese C, Schepisi G, Rossetti S, Maines F, Kinspergher S, Fratino L, Ermacora P, Nicodemo M, Giordano M, Sartori D, Scapoli D, Sabbatini R, Lo Re G, Morelli F, D'Angelo A, Vittimberga I, Lippe P, Carrozza F, Messina C, Galli L, Valcamonico F, Porta C, Pappagallo G, Aglietta M. Caffo O, et al. Among authors: maines f. Eur J Cancer. 2021 Sep;155:56-63. doi: 10.1016/j.ejca.2021.06.016. Epub 2021 Aug 3. Eur J Cancer. 2021. PMID: 34358777 Clinical Trial.
65 results